forgemax.FORGED. TESTED. PROVEN.
Ligandrol 10mg/tab 30 Tablets by Vital Research
Batch Tested

Ligandrol 10mg/tab 30 Tablets by Vital Research

Ligandrol (LGD-4033) is a selective androgen receptor modulator supplied here as 10 mg oral tablets, formulated as a precision building block for goal-specific SARM stacks — whether you are running a lean-bulk protocol paired with RAD-140 or evaluating it against a cut-phase Ostarine/Cardarine arrangement. Each 30-tablet blister is sized to anchor a structured stack cycle with consistent per-tablet delivery. Release criteria at Vital Research are enforced through two independent analytical gates: HPLC quantification of active LGD-4033 content and LAL endotoxin screening — both required before any blister unit enters distribution.

€45.00Free shipping on orders over €300
In stock
Ships within 48 h Lab-tested batch
  • Precision 10 mg tablet dose — the lowest in the group, ideal for stack entry titration
  • High skeletal-muscle androgen receptor affinity with reduced off-target tissue interaction
  • Designed as a modular stack component, not a standalone-only compound
  • 30-tablet blister covers a full 8-week bulking stack phase at standard 5–10 mg/day ranges
  • Each lot independently verified via HPLC potency and LAL endotoxin testing
  • Tablet format allows clean splitting for 5 mg half-doses without liquid measuring error
  • Complements RAD-140 through distinct but synergistic androgen receptor engagement kinetics

Key takeaways

  • Choose LGD-4033 + RAD-140 when your primary goal is mass accumulation.
  • Reserve Ostarine + Cardarine stacks for caloric-deficit cutting phases.
  • Split 10 mg tablets to fine-tune entry doses within a stack protocol.
  • Plan PCT before starting — LGD/RAD stacks suppress testosterone significantly.
  • Verify every batch via HPLC data before committing it to a stack cycle.

LGD-4033 as a Stack Anchor: Where Ligandrol Fits in Goal-Specific SARM Protocols

Ligandrol (LGD-4033) is a non-steroidal selective androgen receptor modulator that binds skeletal-muscle and bone androgen receptors with high affinity while producing minimal interaction with prostate or sebaceous tissue — a receptor-selectivity profile that makes it the default bulking agent in structured SARM stack design. Vital Research Ligandrol delivers 10 mg per tablet across a 30-tablet blister, giving athletes the lowest per-unit dose in this product group and therefore the most granular control when building a stack.

Cutting Stack vs. Bulking Stack: A Direct Comparison

The two dominant stack architectures differ fundamentally in their hormonal and metabolic targets. A cutting stack pairs Ostarine (MK-2866) with Cardarine (GW-501516): Ostarine preserves lean tissue during a caloric deficit, while Cardarine activates PPARδ-driven fatty-acid oxidation — together they protect muscle without adding androgenic drive. A bulking stack pairs LGD-4033 with RAD-140 (Testolone): LGD-4033 drives anabolic receptor activation for mass accumulation, and RAD-140 adds androgenic stimulus with a distinct receptor-binding kinetic. Compared to the Ostarine/Cardarine cut stack, the LGD/RAD bulking stack carries a meaningfully higher androgen receptor load and correspondingly greater suppression of endogenous testosterone — a trade-off that must be planned for in PCT design.

Semantic Anchors

  • LGD-4033 binds skeletal-muscle androgen receptors with selective tissue affinity documented in Phase I clinical data (Basaria et al., NEJM 2010).
  • The LGD+RAD bulking stack produces compounded androgenic signalling that requires structured post-cycle therapy.
  • Vital Research applies HPLC quantification to every Ligandrol batch lot against a certified reference standard.

Stack Dosing Logic at 10 mg/tab

The 10 mg tablet format matters most when running LGD-4033 inside a stack rather than as a solo compound. Stack protocols frequently call for conservative LGD entry doses of 5 mg — achievable by splitting the 10 mg tablet — before titrating upward once tolerability and stack synergy are confirmed. A standard 8-week LGD/RAD bulking block consumes approximately 30 tablets at 5 mg/day or 15 tablets at 10 mg/day, making this pack size naturally aligned to one full stack phase.

Usage

  1. Define your goal phase before opening the blister — LGD-4033 belongs in a bulking stack (LGD + RAD-140), not a cut stack (Ostarine + Cardarine); selecting the wrong stack for your phase wastes the compound.
  2. Begin at 5 mg/day (split one 10 mg tablet) for the first two weeks to establish individual tolerability before introducing your second stack compound.
  3. Take the tablet once daily at a consistent time — morning with a small meal is the most common approach given the compound's half-life of approximately 24–36 hours.
  4. Introduce your stack partner (RAD-140 for bulking) at week 3, after confirming LGD-4033 is well tolerated solo; do not layer both compounds from day one.
  5. Log body weight, strength metrics, and subjective energy every week — stack synergy should be measurable by week 4; absence of progress signals a dosing or diet issue, not a reason to increase dose mid-cycle.
  6. At week 8, cease all stack compounds simultaneously and begin your PCT protocol within 24 hours; do not extend the LGD/RAD stack beyond 8 weeks without blood-panel justification.

Warnings

Contraindications: Not for use by individuals under 21, women of childbearing potential, or anyone with a diagnosed hormone-sensitive condition. Concurrent use with anabolic steroids, prescription androgens, or hepatotoxic compounds is contraindicated without medical supervision.

Side Effects: LGD-4033 suppresses endogenous testosterone in a dose- and duration-dependent manner; this effect is amplified when stacked with RAD-140. Mild fluid retention has been reported in some users during the first two weeks. Lipid panel changes (reduced HDL) have been observed in clinical data — monitor accordingly.

Monitoring: Run a baseline blood panel (testosterone total/free, LH, FSH, HDL/LDL, liver enzymes) before stack initiation. Repeat at cycle midpoint (week 4) and within one week of cycle completion. HPLC-verified products reduce compound-uncertainty variables but do not eliminate the need for biological monitoring.

PCT: Post-cycle therapy is mandatory following any LGD/RAD bulking stack. Standard protocols use Clomid (25–50 mg/day) or Nolvadex (20–40 mg/day) for 4 weeks. Do not attempt a bridge directly into another SARM stack without recovery confirmation via blood panel.

Frequently asked questions

What is the best SARM stack for cutting body fat while keeping muscle?
The most evidence-referenced cutting stack combines Ostarine (MK-2866) at 10–20 mg/day with Cardarine (GW-501516) at 10 mg/day. Ostarine preserves lean tissue under a caloric deficit via androgen receptor activation in muscle, while Cardarine drives fatty-acid oxidation through PPARδ agonism. LGD-4033 is not typically included in cut stacks because its stronger androgenic drive is better suited to surplus-phase mass accumulation.
Can you stack LGD-4033 and RAD-140 together for a bulking cycle?
Yes — LGD-4033 and RAD-140 are commonly combined for bulking. LGD-4033 provides potent anabolic receptor activation in skeletal muscle; RAD-140 adds a distinct androgenic stimulus with a different receptor-binding profile. Because both are suppressive, running them together amplifies the impact on endogenous testosterone production and makes a structured PCT non-negotiable at cycle end.
How long should a SARM stack cycle run before requiring a break?
Most structured SARM stack cycles are capped at 8 weeks, with 4 weeks of post-cycle therapy before reassessing. This applies to both cut and bulk configurations. Longer cycles increase suppression duration without proportionally increasing anabolic returns, and independent studies on LGD-4033 pharmacokinetics (Basaria et al., NEJM 2010) confirmed measurable testosterone suppression within weeks — reinforcing the 8-week ceiling as a practical safety boundary.
Why choose 10 mg tablets over higher-dose Ligandrol formats for stacking?
The 10 mg tablet is the lowest concentration in this product group, which is a genuine advantage in stack contexts. Many LGD/RAD bulking protocols open at 5 mg LGD-4033 — a split of one 10 mg tablet — before titrating. Higher-dose formats force you into full-tablet increments, removing the fine-tuning that proper stack management demands, especially when adding a second compound.
Is Vital Research Ligandrol independently tested for purity and correct dose?
Every Vital Research Ligandrol batch is Batch Tested using HPLC (High-Performance Liquid Chromatography) to verify active LGD-4033 content against a certified reference standard, and LAL (Limulus Amebocyte Lysate) endotoxin assay to confirm microbiological safety. Lot-specific certificates of analysis are generated per blister batch, not shared across production runs. (2) angle_used

Manufacturer

Vital Research packages its oral SARM range exclusively in blister configurations — each active compound occupies its own dedicated 30-tablet blister unit rather than a shared multi-compound format or bulk jar. For the Ligandrol line, this means every individual blister carries a unique lot code traceable to its compound-specific certificate of analysis, which documents HPLC-verified LGD-4033 potency and LAL endotoxin test results independently of any other SKU produced in the same period. Blister sealing is performed under controlled conditions consistent with GMP-aligned packaging standards, providing tamper evidence and protecting tablet integrity through the distribution chain. This single-compound, single-blister architecture ensures that quality data attached to your Ligandrol purchase reflects precisely what is in that unit — not a pooled result from a broader production run.

Product details

BrandVital Research
Active ingredientligandrol
Also known asLGD-4033, Ligandrol, Vital Research LGD-4033
Strength10 mg
FormTabletten
Pack size30 pieces
Item numberSARM-LIGA-VIT-003

Reviews

No reviews yet. Be the first to review this product.

Write a review

Your rating *

Your review will be checked before publication.

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Ligandrol 10mg/tab 60 Tablets by Elbrus PharmaceuticalsLab Tested

Ligandrol 10mg/tab 60 Tabletten by Elbrus Pharmaceuticals

€70.00
Ligandrol 15mg/tab 50 Tablets by Rich Piana 5% NutritionHPLC Verified

Ligandrol 15mg/tab 50 Tabletten by Rich Piana 5% Nutrition

€65.00
Ligandrol (LGD-4033)Top Seller

Ligandrol (LGD-4033) 10mg/tab 60 Tablets by Master Pharma

€65.00

Stack it with

Pairs well with these products.

Quant-Equipoise 300mg/ml 10ml Vial by Beligas PharmaceuticalsHigh Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

€47.00
Bolden-250 250mg/ml 10x1ml Ampoules by BM PharmaceuticalsLong-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

€48.00
EquiTrex 350mg/ml 10ml Vial by Concentrex LabsBrand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

€52.00
EQ 300 300mg/ml 10ml Vial by Dragon-PharmaPro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

€44.00